The intracellular trafficking and proteolytic processing of the membrane-bound amyloid precursor protein (APP) are coordinated events leading to the generation of pathogenic amyloid-beta (Aβ) peptides. The membrane transport of newly synthesized APP from the Golgi to the endolysosomal system is not well defined, yet it is likely to be critical for regulating its processing by β-secretase (BACE1) and γ-secretase. Here, we show that the majority of newly synthesized APP is transported from the trans-Golgi network (TGN) directly to early endosomes and then subsequently to the late endosomes/lysosomes with very little transported to the cell surface.
early endosomes, with very little transported to the cell surface. Moreover, we have discovered that post-Golgi transport of APP is regulated by an Arf-like small G protein, Arl5b, and the AP complex, AP4. Disruption of Arl5b/AP4 function increases Aβ production, demonstrating that the TGN is an important intracellular site for APP processing. Our findings highlight the importance of the intracellular trafficking of APP and demonstrate that the post-Golgi trafficking of newly synthesized APP is relevant for the regulation of Aβ production.
| RESULTS

| Newly synthesized APP traffics from TGN to early endosomes
To investigate the membrane transport of APP we generated a stable A number of new synthesized cargos traffic to the PM via the recycling endosomes. 15 To investigate if newly synthesized APP also traffics to the recycling endosomes from the TGN, the localization of APP with the recycling endosome marker, Rab11, was examined. In untreated cells, there was minimal overlap of APP with Rab11 (<10%) ( Figure 1D ).
Very little overlap between APP and Rab11 was also observed over an extended 7-hour chase period following CHX washout ( Figure 1D and Figure S2 ), indicating that very little, if any, newly synthesized APP is transported from the Golgi to the recycling endosomes.
Taken together, these results show that newly synthesized APP exits the TGN and is transported to endosomes. Moreover, the kinetics of APP trafficking strongly suggests that APP traffics directly to the early endosomes.
| Newly synthesized APP is transported by a direct route to the endosomal pathway
The findings above suggest a direct transport of APP from the TGN to the early endosomes. Subsequent trafficking of APP from the early endosomes to the late endosomes could either be a direct transport step or an indirect pathway initially to the PM followed by rapid internalization. To determine whether newly synthesized APP was transported to the PM, HeLa cells stably expressing APP 695wt were treated with CHX for 4 hours as previously, the drug was removed for 1 hour 15 minutes to allow newly synthesized APP to accumulate in the Golgi and early endosomes and then Pitstop 2, an inhibitor of clathrin that selectively blocks clathrin-mediated endocytosis, 30 was added to block AP2/clathrin-dependent endocytosis from the PM (Figure 2A, the early endosome and the late endosome were unaffected by Pitstop 2 ( Figure 2C ) and the distribution between the early and late endosomes was very similar to the previous experiment (Figure 1 ), indicating that the bulk of the APP was transported to late endosomes directly from the early endosomes. Very little APP was detected at the cell surface after a 45-minute Pitstop 2 treatment, whereas Pitstop 2 resulted in the accumulation of the transferrin receptor at the cell surface ( Figure 2D and Figure S3 ), indicating that clathrin-mediated endocytosis had indeed been blocked by this inhibitor.
| APP distribution is not altered by Arf1 depletion
The TGN AP complex, AP4, has been shown to interact with the YKFFE sorting motif on the cytoplasmic tail of APP and to regulate the transport of APP from the TGN. 10 AP complexes are recruited to the TGN membranes by small G proteins of the Arf/Arl family. In a previous study from the same group, they showed that the small G protein Arf1 is able to interact with AP4, based on a yeast 2-hybrid assay, and these authors proposed that the recruitment of AP4 to the TGN is regulated by Arf1. 26 However, whether Arf1 regulates APP anterograde transport from the Golgi is unknown. To examine if Arf1 is involved in AP4-mediated APP trafficking, Arf1 was depleted in HeLa cells stably expressing APP 695wt using 2 siRNA target sequences to Arf1, and the steady-state distribution of APP was then analyzed. If Arf1 is required for the post-Golgi export of APP, APP would be expected to accumulate in the TGN. Both siRNA target sequences were successful in depleting Arf1 protein levels by >90%
( Figure 3A) ; however, depletion of Arf1 by either Arf1 siRNA showed no change in the distribution of APP ( Figure 3B) positive control for the loss of function of Arf1 we next depleted both Arf1 and Arf4 simultaneously and obtained a >90% depletion for Arf1 and 70% depletion for Arf4 ( Figure 3B ). Depletion of both Arf1/Arf4 resulted in loss of AP1γ from the Golgi ( Figure 3E ), as expected. However, only low levels of APP colocalized with the TGN marker in double knockdown cells, as for the single knockdown of Arf1 ( Figure 3D ), findings which demonstrate that Arf1 is unlikely to be involved in regulating the post-Golgi trafficking of APP.
| Depletion of the TGN-localized Arl5b alters APP distribution
As Arf1 is unlikely to regulate APP anterograde transport, we sought to identify a small G protein that could regulate post-Golgi APP transport. Work from our laboratory has demonstrated that Arl5b is located at the TGN and regulates transport between the endosome and TGN transport. 32 Given a potential role of Arl5b in TGN to endosome transport, we examined whether Arl5b might regulate the post- we used a CD8/APP construct containing the luminal and transmembrane domains of CD8 fused to the cytoplasmic tail of APP, as described previously. 29 Arl5b depletion also shifted the distribution of CD8/APP to the TGN with the level of colocalization of CD8/APP and the TGN marker GCC88 similar to that observed for full-length APP ( Figure 5A ,B). Hence, collectively these data show that Arl5b may be involved in the post-Golgi transport of APP.
Previously, work in our laboratory showed that Arl5b depletion did not affect the anterograde transport of E-cadherin, a membrane protein that utilizes the transport route to the PM via the recycling endosomes. 32 Hence, Arl5b may regulate post-Golgi transport selectively to early/late endosomes. To assess whether Arl5b depletion impacted on post-Golgi export of other proteins from the TGN, the effects of Arl5b depletion on BACE1 distribution were also investigated. Arl5b depletion using either Arl5b-1 or Arl5b-2 siRNAs had no effect on BACE1 distribution ( Figure S5 ). These data indicate that the effect of Arl5b depletion is specific for the post-Golgi transport of APP. Moreover, the findings also imply that APP and BACE1 are segregated into distinct anterograde transport pathways from the TGN.
To investigate a potential relationship between Arl5b and AP4, we depleted the μ subunit of AP4 in HeLa cells stably expressing 
| AP4 interacts with Arl5b
As the depletion of Arl5b had a similar effect as AP4 depletion on APP post-Golgi trafficking, we investigated whether Arl5b was required for the recruitment of AP4 to TGN membranes. If this was the case, then Arl5b and AP4 may interact and co-precipitate. To examine this possibility, we used HeLa cells stably expressing were transfected with either control siRNA, Arf1 and/or Arf4 siRNAs for 72 hours. A and B, Cells were lysed in SDS-PAGE reducing buffer and cell extracts were subjected to SDS-PAGE on 4% to 12% gradient polyacrylamide gel. Proteins were transferred to a PVDF membrane and probed with (A) mouse polyclonal anti-Arf1 antibody and mouse anti-α-tubulin antibody and (B) mouse anti-AP1γ antibody, mouse polyclonal anti-Arf1 antibody, rabbit anti-Arf4 antibody and mouse anti-α-tubulin antibody using a chemiluminescence detection system. C, HeLa cells stably expressing APP 695wt monolayers were fixed, permeabilized and blocked before staining with mouse monoclonal anti-human APP antibodies (red) and rabbit polyclonal antibodies to GCC88 (green). Higher magnification of the merged images is also shown. Bars represent 10 μm. D, The percentage of APP at the TGN was calculated from the percentage of total APP pixels that overlapped with GCC88. All calculations were performed using the OBCOL plugin on ImageJ (n = 15 for each marker and condition from 3 independent experiments). Error bars represent SEM. E, HeLa cells monolayers were fixed, permeabilized and blocked before staining with mouse anti-AP1γ antibody (red) and rabbit polyclonal antibodies to GCC88 (green).
constitutive active Arl5b(Q70L)-GFP. Arl5b(Q70L) was used to ensure Arl5b is localized to membranes and interacts with its effectors. HeLa cells expressing Arl5b(Q70L)-GFP were lysed and Arl5b-GFP was immunoprecipitated using monoclonal antibodies to the GFP tag.
Immunoprecipitated complexes were then analyzed by immunoblotting for the AP4μ subunit. This analysis showed that Arl5b-GFP coimmunoprecipitated AP4μ as well as another subunit in the AP4 protein complex, AP4ε ( Figure 8A ). In contrast, neither Arf1 nor AP1γ, a subunit of the AP1 AP complex localized to the TGN, was immunoprecipitated with Arl5b-GFP ( Figure 8A ). In addition, the AP4μ subunit was not detected in a GFP immunoprecipitate of cell lysates from cells transfected with the GFP vector alone, confirming the specificity of the pull down ( Figure 8A ). Taken together, these results suggest that Arl5b interacts specifically with AP4.
| Arl5b recruits AP4 to membranes
We next examined whether Arl5b and AP4 were colocalized in vivo.
As the antibodies to AP4μ do not detect endogenous AP4μ by immunofluorescence, we analyzed the location of AP4ε. Dual localization of Arl5b-GFP and AP4ε showed considerable overlap by confocal microscopy ( Figure 8B ). As expected, Arl5b also showed considerable overlap with the TGN marker GCC88, indicating that Arl5b and AP4 colocalized within the same domains of the TGN. To examine if Arl5b was required to recruit AP4 to the TGN membranes, we analyzed the distribution of AP4ε following depletion of Arl5b. Silencing of Arl5b resulted in a considerable reduction of AP4ε fluorescence in the Golgi region, whereas AP4ε remained located at the Golgi after Arf1 depletion ( Figure 8C ) or double knockdown of Arf1 and Arf4 (data not FIGURE 4 Arl5b depletion results in APP accumulation in the TGN. A and B, HeLa cells stably expressing Arl5b(Q70L)-GFP were transfected with either control siRNA or Arl5b siRNAs for 72 hours. A, Cells were lysed in SDS-PAGE reducing buffer and cell extracts were subjected to SDS-PAGE on 4% to 12% gradient polyacrylamide gel.
Proteins were transferred to a PVDF membrane and probed with rabbit anti-GFP antibody and mouse anti-α-tubulin antibody, using a chemiluminescence detection system. B, Monolayers were fixed, permeabilized, stained with DAPI (blue) and Arl5b-GFP detected by GFP fluorescence. C, HeLa cells stably expressing APP 695 were transfected with either control siRNA or Arl5b siRNAs for 72 hours. Monolayers were fixed and permeabilized and stained with mouse monoclonal anti-human APP antibodies (red) and rabbit antibodies to GCC88 (green). Higher magnification of the merged images is also shown. D, The percentage of APP at the TGN was calculated from the percentage of total APP pixels that overlapped with GCC88. Calculation was performed using the OBCOL plugin on ImageJ (n = 15 for each marker and condition from 3 independent experiments). Error bars represent SEM. ***P < .001, E, Expression of an siRNA-1-resistant Arl5b-GFP construct (Arl5b-Rescue-GFP) in Arl5b-1 siRNA-treated HeLa cells stably expressing APP 695wt . Cell expressing the Arl5b-GFP rescue construct is outlined. Bars represent 10 μm. or AP4μ depletion did not result in AP1 dissociation from the TGN in FIGURE 5 Arl5b depletion results in CD8/APP accumulation in the TGN. A, HeLa cells were transfected with either control siRNA or Arl5b siRNAs for 48 hours and then transfected with CD8/APP constructs for 24 hours. After 24 hours, monolayers were fixed and permeabilized and then stained with mouse polyclonal anti-CD8 antibodies (red) and GCC88 (green). Higher magnification of the merge images is also shown. Bars represent 10 μm. B, The percentage of CD8-APP at the TGN was calculated from the percentage of total CD8/APP pixels that overlapped with GCC88. All calculations were performed using the OBCOL plugin on ImageJ (n = 15 for each marker and condition from 3 independent experiments). Error bars represent SEM. ***P < .001. FIGURE 6 AP4μ depletion results in APP accumulation in the TGN. A, Quantitative PCR (qRT-PCR) analysis of AP4μ depletion. Total RNA was isolated from HeLa cells transfected with either control siRNA or AP4μ siRNAs for 72 hours. Total RNA was converted to cDNA to setup singleplex reactions in quadruplicate for AP4 with the internal endogenous reference gene, GAPDH. qRT-PCR was performed using the comparative DeltaDelta CT method. Relative quantification of mRNA levels was achieved using control siRNA as the normalizer. Data were pooled from 3 independent experiments and analyzed by a paired, two-tailed Student's t-test. B, HeLa cells stably expressing APP 695wt were transfected with either control siRNA or AP4μ siRNAs for 72 hours. Monolayers were fixed and permeabilized and stained with mouse monoclonal anti-human APP antibodies (red) and GCC88 (green). Higher magnification of the merges images is also shown. Bars represent 10 μm. C, The percentage of APP at the TGN was calculated from the percentage of total APP pixels that overlapped with GCC88 using the OBCOL plugin on ImageJ. Data are pooled from 3 independent experiments and expressed as the mean AE SEM (n = 15) and analyzed by an unpaired, two-tailed Student's t-test. ***P < .001. 
| Impact of Aβ production by Arl5b and AP4 knockdown
To assess whether Arl5b and AP4 depletion alters Aβ production, conditioned media were collected from HeLa cells stably expressing APP 695wt . Secreted APP processing products produced from APP cleavage by endogenous BACE1 were analyzed for the presence of Aβ using a sandwich ELISA specific for Aβ 40 . The levels of Aβ for each sample were normalized against total cell protein levels. There was an approximately 2.9-and 3.2-fold increase in Aβ production in Arl5b-and AP4μ-depleted conditions, respectively, as compared to control siRNA conditions ( Figure 10A) . A similar fold increase in Aβ production was also observed when AP4ε was knocked down (not shown).
The level of sAPPα, a product from the non-amyloidogenic processing of APP, was very similar in all siRNA-treated cells, indicating that the efficiency of non-amyloidogenic processing of APP was not affected by Arl5b or AP4μ depletion ( Figure 10B ,C). Given that intact APP accumulated in the TGN, this finding indicates that the nonamyloidogenic processing of APP can probably occur in multiple locations including the TGN as previously suggested. 2 Aβ production is a measurement of cleavage by both BACE1 and γ-secretase. To directly assess the cleavage of APP by BACE1 we performed the experiment in the presence and absence of the γ-secretase inhibitor, DAPT, and assessed the levels of β-CTF/C99, the product of APP-BACE1 cleavage. For this experiment we silenced AP4ε and immunoblotting showed a reduction in protein levels by approximately 90%
( Figure 10D ). In the absence of DAPT, β-CTF/C99 was not detected in control siRNA-treated cells and only at very low levels in Arl5b siRNAor AP4ε siRNA-treated cells. However, in the presence of DAPT the levels of intracellular β-CTF/C99 were increased ( Figure 10D ) and there was a 3-fold increase in the level of β-CTF/C99 in Arl5b siRNA-or AP4ε siRNA-treated cells compared with control siRNA-treated cells ( Figure 10D ,E). The increase in the level of the β-CTF/C99 product demonstrates enhanced intracellular cleavage of APP by BACE1 following depletion of the TGN-localized components Arl5b and AP4.
Taken together, these results demonstrate that both Arl5b and AP4 are important in the regulation of APP trafficking from the TGN and are required to regulate Aβ production. In addition, these results further support that the Golgi is a compartment where APP can be processed and result in Aβ production.
| DISCUSSION
The intracellular itinerary of APP is important in the regulation of its proteolytic processing by BACE1 and γ-secretase. The initial cleavage of APP by BACE1 is the rate-limiting step in the generation of Aβ and a target for therapeutic intervention. Several AD susceptibility genes are associated with the regulation of membrane trafficking [35] [36] [37] [38] [39] [40] [41] and there is emerging evidence in experimental animal models that defective membrane trafficking contributes to AD. [42] [43] [44] In particular, dysfunctional endosomal trafficking of APP and BACE1 has attracted considerable attention over the past few years as an underlying defect associated with enhanced Aβ generation. However, in addition to Aβ generation in the endo/lysosomal system there have been numerous studies to indicate that Aβ can also be generated in the secretory pathway. [8] [9] [10] [11] [12] 29 The TGN is a slightly acidic compartment that provides favourable conditions for cleavage of APP by BACE1.
Given the co-transport of newly synthesized APP and BACE1 along the secretory pathway it is important to understand the machinery for post-Golgi export and the transport route of APP from the Golgi to the endosomes.
Here, we have examined the post-Golgi transport of APP and have shown that (1) Of note is that very little APP was detected at the cell surface either under steady-state conditions or by tracking the newly synthesized APP, a finding consistent with reports in the literature. 47 Our finding that the major pathway of APP transport from the Golgi is to the early endosomes and then to the late endosomes, and not to the cell surface, highlights the importance of post-Golgi export of APP in the delivery to the endo/lysosomal system. Hence, endocytosis of APP from the PM to the early endosomes is probably a minor pathway for the delivery of APP to the endosomal system.
AP4 has previously been shown to interact with the YKFFE sorting motif on APP via the μ subunit 10 and to regulate the post-Golgi trafficking of APP from the TGN to the endosomes. 10 However, this earlier study did not identify whether the compartment was an early, late or recycling endosome and did not determine whether the transport was direct or indirect to the endosomal compartment. Here, we have confirmed the importance of AP4 using a APP 695wt -expressing HeLa cell line and showed that APP is transported directly from the TGN to the early endosomes. Although Arf1 has previously been reported to interact with AP4 in yeast-2-hybrid studies, 26 it was unknown whether Arf1 could interact and recruit AP4 in mammalian cells. We were unable to detect any change in the distribution of APP following Arf1 depletion or Arf1+ Arf4 depletion in vivo. We interpret these findings that AP4 recruitment to the Golgi does not require Arf1 and this raised the possibility of another small G protein responsible for recruiting AP4 to the TGN membranes.
In a previous study, Arl5b was shown to localize to the TGN and the silencing of Arl5b slows down trafficking of cargos from endosomes to the TGN. 32 Based on these observations we had proposed that Arl5b may mediate the transport of machinery from the TGN to the endosomes, which would account for the reduced efficiency of retrograde transport from endosomes to the TGN. 32 Here, we have However, whether the interaction is direct or indirect remains to be shown.
In contrast to APP, Arl5b depletion did not affect the distribution of BACE1, indicating that the machinery and transport pathways that regulate APP and BACE1 export from the TGN differ, as outlined in the proposed model in Figure 11 . Sorting of BACE1 and APP into distinct pathways would provide a mechanism for segregation of these 2 membrane proteins at the TGN and thereby reducing the extent of BACE1-mediated processing of APP.
Our study indicates that AP4-mediated Golgi export represents a major pathway for delivery of APP cargo to the endosomal system.
Upon depletion of either Arl5b or AP4μ it was noted that there was residual APP in punctate endosomal structures. This could be due to incomplete depletion of machinery component or a consequence of TGN export mediated by an AP4-independent pathway. One possibility is the involvement of Mint adaptors 48 that are localized to multiple locations such as the TGN, ER or PM. 27 In particular, Mint3 has been shown to bind to the GYENPTY motif in cytoplasmic tail of APP and Mint3 is recruited to the Golgi following transient expression of APP in HeLa cells. 48 These authors reported a rapid Golgi export of APP in transiently transfected cells to the LAMP1-positive endosomes, a finding that is difficult to reconcile with the location of the major fraction of APP to early endosomes under steady-state conditions. A major difference in the previous study by Caster and Kahn 48 is the use of a transient transfection system in their study, which is likely to result a higher level of APP expression and, given that AP4 levels are low in HeLa cells, the Arl5b/AP4 sorting system may be readily saturated upon high expression of APP. Our findings show that, at a modest level of expression, APP is transported to the early endosomes in an AP4-dependent pathway, and given the report by
Caster and Kahn 48 we suggest that at higher levels of expression excess APP may be transported directly to late endosomes/lysosomes via the Mint3-dependent pathway.
The current data also lend further support for a contribution of 
| MATERIALS AND METHODS
| Plasmids, antibodies
pIRESpuro-APP 695wt was a gift from Prof. Andrew F. Hill, La Trobe University, Victoria, Australia. 49 pCI-Neo-CD8-APP 695wt has been described previously. 29 Rabbit polyclonal antibodies to GCC88 have been described. 50, 51 Mouse monoclonal antibodies to AP4ε-subunit FIGURE 11 Model of anterograde transport of newly synthesized APP and BACE1. Both APP and BACE1 are synthesized as membrane proteins in the ER and subsequently are transported to the Golgi. At the TGN the 2 membrane cargos follow distinct pathways to the plasma membrane, APP is transported by an Arl5b-and AP4-dependent pathway to the early endosome then late endosomes whereas BACE1 is proposed to be transported either directly to the plasma membrane or indirectly via recycling endosomes.
(clone 32) and AP1 γ-adaptin (clone 88) were purchased from Trans- 
| Generation of stable cell line
A HeLa cell line stably expressing APP 695wt was generated by transfecting wild-type HeLa cells with the pIRESpuro-APP 695wt construct using FuGene 6 (Roche). Stably expressing cells were selected in C-DMEM (Life Technologies) with 1 μg/mL puromycin (Invitrogen). Monoclonal cell lines were obtained using limit dilution and resultant cell populations screened by immunofluorescence and immunoblotting. The stable cell line was maintained in C-DMEM with 500 ng/mL puromycin.
| RNA interference
For short interfering RNA (siRNA) transfections, cell monolayers were transfected with siRNA (0.08 μM/well) using Dharmafect 1 (ThermoFisher) according to the manufacturer's protocol. Transfected cells were incubated for 72 hours at 37 C, 10% CO 2 . Arl5b-1-and Arl5b-2-specific siRNA duplexes were described by Houghton et al.
32
AP4μ-1 siRNA has been described by Janvier et al 52 and AP4μ-2 siRNA was as follows: CGCAAUGUGGCUCUGGUAU. AP4ε-1 and AP4ε-2 siRNAs (Sigma-Proligo database) were CUUGAUG-AAUCCUUACGAA and GGCAUAUGAAGAUGAUUAU, respectively.
Arf1-1 siRNA has been described 53 
| Indirect immunofluorescence
Monolayers on coverslips were fixed in 4% paraformaldehyde (PFA)
for 15 minutes at room temperature, followed by quenching in Confocal microscopy was performed using a Leica TCS SP2 or SP8 system. Images were collected sequentially for multicolour imaging.
| Analysis of AP4ε fluorescence in Golgi vs cytoplasm
FIJI (ImageJ) was used for image analysis. To calculate the fluorescence signal of AP4ε at the TGN compared with the cytoplasm in stained HeLa cells, a TGN mask and nuclear mask were generated using GCC88-and DAPI-specific fluorescence signals, respectively, using FIJI (ImageJ). The AP4ε fluorescence intensity in the TGN and nuclear mask was then subtracted from the total fluorescence intensity of AP4ε in the cell to obtain the AP4ε fluorescence signal in the cytoplasm. The fluorescence signal of AP4ε at the TGN is expressed as a ratio of the fluorescence signal of AP4ε in the cytoplasm. All fluorescence images were collected with the Leica SP8 microscope using identical settings.
| Immunoblotting
Samples with equal cell number were lysed in 4× reducing sample buffer and boiled for 5 minutes at 100 C. Protein concentration was 
| Aβ ELISAs
Secreted Aβ 40 levels from overnight conditioned media were measured using an Aβ 40 -specific Aβ ELISA kit (Life Technologies) as per manufacturer's protocol. Secreted Aβ levels were normalized against total protein concentrations of cell lysates as measured using a Bradford assay.
| Quantitation of colocalization and statistical analysis
Quantitation of the colocalization between internalized cargo and fluorescent organelle markers was performed using the plugin organelle-based colocalization (OBCOL) 54 experiments. Data were expressed as the mean AE SEM and analyzed by either an unpaired, two-tailed, Student's t test or in the case of the qPCR data analyzed by a paired, two-tailed Student's t test. A *P < .05 was considered significant, **P < .01 was highly significant and ***P < .001 was very highly significant. An absence of a P value indicates that the differences were not significant. 
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